Literature DB >> 3365571

The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation.

R M Niles1, S A Wilhelm, P Thomas, N Zamcheck.   

Abstract

The effect of sodium butyrate and retinoic acid added singly or in combination on substrate-dependent growth, colonization efficiency in soft agar, and carcino-embryonic antigen (CEA) production in three human colorectal carcinoma cell lines differing in their degree of differentiation was studied. All three colon cancer cell lines regardless of their state of differentiation had their growth markedly slowed by sodium butyrate, and to a lesser extent by retinoic acid. When both agents were added together, a small synergistic inhibition of growth was noted in all the cell lines. Butyrate eliminated colony formation in soft agar in all three cell lines, however, retinoic acid only reduced colony formation in the well differentiated cell line DLD-2. Sodium butyrate was able to induce CEA production in the undifferentiated cell (MIP-101) and the moderately differentiated cells (clone D) which were previously negative for this marker. It also enhanced the baseline production of CEA in the well differentiated cells (DLD-2). Retinoic acid did not induce CEA production in clone D or MIP-101 cells, but did enhance the production of CEA in DLD-2 cells. When both retinoic acid and sodium butyrate were added together, CEA production was either additive (DLD-2) or was inhibited (clone D and MIP-101). One explanation of these results is that only well differentiated cells have functional cellular retinoic acid-binding protein (cRABP), and that certain actions of retinoic acid (inhibition of anchorage-dependent growth) are independent of the presence of cRABP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365571     DOI: 10.3109/07357908809077027

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  12 in total

1.  Induction of carcinoembryonic-antigen-gene expression in human colorectal carcinoma by sodium butyrate.

Authors:  K Saini; G Steele; P Thomas
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

2.  Induction of carcinoembryonic antigen expression in a three-dimensional culture system.

Authors:  J M Jessup; D Brown; W Fitzgerald; R D Ford; A Nachman; T J Goodwin; G Spaulding
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

3.  Induction of retinoic acid receptor beta mediates growth inhibition in retinoid resistant human colon carcinoma cells.

Authors:  B Nicke; E O Riecken; S Rosewicz
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.

Authors:  J Lundy; A Schuss; D Stanick; E S McCormack; S Kramer; J M Sorvillo
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer.

Authors:  M R Clausen; H Bonnén; P B Mortensen
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

6.  Effects of short chain fatty acids on gut morphology and function.

Authors:  W Scheppach
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 7.  Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.

Authors:  J M Jessup; P Thomas
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

8.  Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer.

Authors:  Ekaterina S Kropotova; Olga L Zinovieva; Alisa F Zyryanova; Vera I Dybovaya; Vladimir S Prasolov; Sergey F Beresten; Nina Yu Oparina; Tamara D Mashkova
Journal:  Pathol Oncol Res       Date:  2014-03-06       Impact factor: 3.201

9.  Differential patterns of expression of glycosylphosphatidylinositol-anchored carcinoembryonic antigen and alkaline phosphatase in various cancer cell lines.

Authors:  K Yoshinari; K Matsumoto; H Misaki
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

10.  Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.

Authors:  Diana C DeLucia; Thomas M Cardillo; Lisa Ang; Mark P Labrecque; Ailin Zhang; James E Hopkins; Navonil De Sarkar; Ilsa Coleman; Rui M Gil da Costa; Eva Corey; Lawrence D True; Michael C Haffner; Michael T Schweizer; Colm Morrissey; Peter S Nelson; John K Lee
Journal:  Clin Cancer Res       Date:  2020-11-16       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.